Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine
On Feb. 26, 2026, Novartis announced it has settled a lawsuit by the estate of Henrietta Lacks that…
-
-
Novartis settles 18-month-old lawsuit from estate of Baltimore woman whose cells were extracted 75 years ago
On Feb. 24, 2026, The family of a Baltimore woman whose cells were extracted for medical research without…
-
Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
-
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
-
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
-
Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
-
CIRM invested $26 million in research
On Mar. 27, 2023, California Institute for Regenerative Medicine (CIRM) Board approved investing nearly $26 million in 17…
-
Biotechnology | Clinical Research | COVID-19 | FDA | HIV | Infectious Disease | Oncology | Therapeutics
CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to Philippines
On Apr. 15, 2021, CytoDyn announced it had executed an exclusive supply and distribution agreement with Chiral Pharma…
-
Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group, a new clinical trial, opened across Canada. This was…
-
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
-
Biotechnology | Diagnostics | FDA | Oncology | Therapeutics
Genentech drug Alecensa (alectinib) was approved by FDA
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…
-
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
-
A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
-
Magnetic Surgery Tested Successfully on First Patient
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
-
The human p53 gene was cloned
On Dec. 20, 1984, a team of scientists announced that a cDNA clone for human p53 cellular tumor…
-
David Baltimore, Renato Dulbecco, and Howard Martin Temin awarded the 1975 Nobel Prize in Medicine
In 1975, Caltech President David Baltimore, former Caltech faculty member and Salk Institute researcher Renato Delbucco, and Caltech…
-
A virus (the Epstein-Barr virus) was linked to human cancer (Burkitt lymphoma) for the first time
In 1964, a new herpesvirus, Epstein-Barr virus (EBV), was discovered in cultured tumor cells derived from a Burkitt…
-
NIH scientists first identified type II cell of pulmonary alveolus as the cell of origin of the common alveologenic tumours of the lungs
In 1939, Hugh G. Grady and Harold L. Stewart first identified the type II cell of the pulmonary…
